Markedsdata leveret af TwelveData og Morningstar
Euroapi S.A. is a pharmaceutical ingredients company specializing in the development, manufacturing, and supply of active pharmaceutical ingredients for healthcare companies worldwide. Its portfolio supports medicines across therapeutic areas such as cardiovascular care, central nervous system treatments, infectious diseases, and other specialized applications. The company provides both established active ingredients and contract development and manufacturing services, helping pharmaceutical and biotechnology customers move products from development through commercial production. Euroapi S.A. operates industrial and research capabilities focused on chemical synthesis, fermentation, process development, analytical testing, and regulatory support. Its activities serve branded-drug manufacturers, generic pharmaceutical companies, and emerging biotechnology businesses that require reliable access to complex pharmaceutical substances. By supplying essential components used in finished medicines, Euroapi S.A. occupies an important position within the pharmaceutical value chain, connecting specialized chemical production with healthcare delivery and supporting the continuity, quality, and regulatory compliance of medicine manufacturing.
Baseret på 4 analytikere